Global Transdermal Skin Patches Market Research Report 2020

Publisher Name :
Date: 07-Apr-2020
No. of pages: 99
Inquire Before Buying

The global Transdermal Skin Patches market is valued at US$ 42 million in 2020 is expected to reach US$ 51 million by the end of 2026, growing at a CAGR of 2.7% during 2021-2026.

This report focuses on Transdermal Skin Patches volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Transdermal Skin Patches market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.

Market Segment Analysis

The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Transdermal Skin Patches market is segmented into

- Drug in Adhesive

- Matrix

- Reservoir

- Vapor

- Other

Segment by Application

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

Global Transdermal Skin Patches Market: Regional Analysis

The Transdermal Skin Patches market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Transdermal Skin Patches market report are:

North America

- U.S.

- Canada

Europe

- Germany

- France

- U.K.

- Italy

- Russia

Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

Latin America

- Mexico

- Brazil

- Argentina

Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Transdermal Skin Patches Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Transdermal Skin Patches market include:

- Johnson & Johnson

- Novartis AG

- Mylan N.V.

- Teva Pharmaceutical Industries

- Luye Pharma Group

- Hisamitsu Pharmaceutical

- Mundipharma International

- Purdue Pharma

Global Transdermal Skin Patches Market Research Report 2020

Table of Contents
1 Transdermal Skin Patches Market Overview
1.1 Product Overview and Scope of Transdermal Skin Patches
1.2 Transdermal Skin Patches Segment by Type
1.2.1 Global Transdermal Skin Patches Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Drug in Adhesive
1.2.3 Matrix
1.2.4 Reservoir
1.2.5 Vapor
1.2.6 Other
1.3 Transdermal Skin Patches Segment by Application
1.3.1 Transdermal Skin Patches Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Transdermal Skin Patches Market Size Estimates and Forecasts
1.4.1 Global Transdermal Skin Patches Revenue 2015-2026
1.4.2 Global Transdermal Skin Patches Sales 2015-2026
1.4.3 Transdermal Skin Patches Market Size by Region: 2020 Versus 2026
2 Global Transdermal Skin Patches Market Competition by Manufacturers
2.1 Global Transdermal Skin Patches Sales Market Share by Manufacturers (2015-2020)
2.2 Global Transdermal Skin Patches Revenue Share by Manufacturers (2015-2020)
2.3 Global Transdermal Skin Patches Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Transdermal Skin Patches Manufacturing Sites, Area Served, Product Type
2.5 Transdermal Skin Patches Market Competitive Situation and Trends
2.5.1 Transdermal Skin Patches Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Transdermal Skin Patches Players (Opinion Leaders)
3 Transdermal Skin Patches Retrospective Market Scenario by Region
3.1 Global Transdermal Skin Patches Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Transdermal Skin Patches Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Transdermal Skin Patches Market Facts & Figures by Country
3.3.1 North America Transdermal Skin Patches Sales by Country
3.3.2 North America Transdermal Skin Patches Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Transdermal Skin Patches Market Facts & Figures by Country
3.4.1 Europe Transdermal Skin Patches Sales by Country
3.4.2 Europe Transdermal Skin Patches Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Transdermal Skin Patches Market Facts & Figures by Region
3.5.1 Asia Pacific Transdermal Skin Patches Sales by Region
3.5.2 Asia Pacific Transdermal Skin Patches Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Transdermal Skin Patches Market Facts & Figures by Country
3.6.1 Latin America Transdermal Skin Patches Sales by Country
3.6.2 Latin America Transdermal Skin Patches Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Transdermal Skin Patches Market Facts & Figures by Country
3.7.1 Middle East and Africa Transdermal Skin Patches Sales by Country
3.7.2 Middle East and Africa Transdermal Skin Patches Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Transdermal Skin Patches Historic Market Analysis by Type
4.1 Global Transdermal Skin Patches Sales Market Share by Type (2015-2020)
4.2 Global Transdermal Skin Patches Revenue Market Share by Type (2015-2020)
4.3 Global Transdermal Skin Patches Price Market Share by Type (2015-2020)
4.4 Global Transdermal Skin Patches Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Transdermal Skin Patches Historic Market Analysis by Application
5.1 Global Transdermal Skin Patches Sales Market Share by Application (2015-2020)
5.2 Global Transdermal Skin Patches Revenue Market Share by Application (2015-2020)
5.3 Global Transdermal Skin Patches Price by Application (2015-2020)
6 Company Profiles and Key Figures in Transdermal Skin Patches Business
6.1 Johnson & Johnson
6.1.1 Corporation Information
6.1.2 Johnson & Johnson Description, Business Overview and Total Revenue
6.1.3 Johnson & Johnson Transdermal Skin Patches Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Johnson & Johnson Products Offered
6.1.5 Johnson & Johnson Recent Development
6.2 Novartis AG
6.2.1 Novartis AG Transdermal Skin Patches Production Sites and Area Served
6.2.2 Novartis AG Description, Business Overview and Total Revenue
6.2.3 Novartis AG Transdermal Skin Patches Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Novartis AG Products Offered
6.2.5 Novartis AG Recent Development
6.3 Mylan N.V.
6.3.1 Mylan N.V. Transdermal Skin Patches Production Sites and Area Served
6.3.2 Mylan N.V. Description, Business Overview and Total Revenue
6.3.3 Mylan N.V. Transdermal Skin Patches Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Mylan N.V. Products Offered
6.3.5 Mylan N.V. Recent Development
6.4 Teva Pharmaceutical Industries
6.4.1 Teva Pharmaceutical Industries Transdermal Skin Patches Production Sites and Area Served
6.4.2 Teva Pharmaceutical Industries Description, Business Overview and Total Revenue
6.4.3 Teva Pharmaceutical Industries Transdermal Skin Patches Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Teva Pharmaceutical Industries Products Offered
6.4.5 Teva Pharmaceutical Industries Recent Development
6.5 Luye Pharma Group
6.5.1 Luye Pharma Group Transdermal Skin Patches Production Sites and Area Served
6.5.2 Luye Pharma Group Description, Business Overview and Total Revenue
6.5.3 Luye Pharma Group Transdermal Skin Patches Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Luye Pharma Group Products Offered
6.5.5 Luye Pharma Group Recent Development
6.6 Hisamitsu Pharmaceutical
6.6.1 Hisamitsu Pharmaceutical Transdermal Skin Patches Production Sites and Area Served
6.6.2 Hisamitsu Pharmaceutical Description, Business Overview and Total Revenue
6.6.3 Hisamitsu Pharmaceutical Transdermal Skin Patches Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Hisamitsu Pharmaceutical Products Offered
6.6.5 Hisamitsu Pharmaceutical Recent Development
6.7 Mundipharma International
6.6.1 Mundipharma International Transdermal Skin Patches Production Sites and Area Served
6.6.2 Mundipharma International Description, Business Overview and Total Revenue
6.6.3 Mundipharma International Transdermal Skin Patches Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Mundipharma International Products Offered
6.7.5 Mundipharma International Recent Development
6.8 Purdue Pharma
6.8.1 Purdue Pharma Transdermal Skin Patches Production Sites and Area Served
6.8.2 Purdue Pharma Description, Business Overview and Total Revenue
6.8.3 Purdue Pharma Transdermal Skin Patches Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Purdue Pharma Products Offered
6.8.5 Purdue Pharma Recent Development
7 Transdermal Skin Patches Manufacturing Cost Analysis
7.1 Transdermal Skin Patches Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Transdermal Skin Patches
7.4 Transdermal Skin Patches Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Transdermal Skin Patches Distributors List
8.3 Transdermal Skin Patches Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Transdermal Skin Patches Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Transdermal Skin Patches by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Transdermal Skin Patches by Type (2021-2026)
10.2 Transdermal Skin Patches Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Transdermal Skin Patches by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Transdermal Skin Patches by Application (2021-2026)
10.3 Transdermal Skin Patches Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Transdermal Skin Patches by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Transdermal Skin Patches by Region (2021-2026)
10.4 North America Transdermal Skin Patches Estimates and Projections (2021-2026)
10.5 Europe Transdermal Skin Patches Estimates and Projections (2021-2026)
10.6 Asia Pacific Transdermal Skin Patches Estimates and Projections (2021-2026)
10.7 Latin America Transdermal Skin Patches Estimates and Projections (2021-2026)
10.8 Middle East and Africa Transdermal Skin Patches Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Transdermal Skin Patches Sales (K Pcs) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Transdermal Skin Patches Sales (K Pcs) Comparison by Application: 2020 VS 2026
Table 3. Global Transdermal Skin Patches Market Size by Type (K Pcs) (US$ Million) (2020 VS 2026)
Table 4. Global Key Transdermal Skin Patches Manufacturers Covered in This Study
Table 5. Global Transdermal Skin Patches Sales (K Pcs) by Manufacturers (2015-2020)
Table 6. Global Transdermal Skin Patches Sales Share by Manufacturers (2015-2020)
Table 7. Global Transdermal Skin Patches Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Transdermal Skin Patches Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Transdermal Skin Patches Average Price (USD/Pcs) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Transdermal Skin Patches Sales Sites and Area Served
Table 11. Manufacturers Transdermal Skin Patches Product Types
Table 12. Global Transdermal Skin Patches Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Transdermal Skin Patches by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Skin Patches as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Transdermal Skin Patches Players
Table 16. Global Transdermal Skin Patches Sales (K Pcs) by Region (2015-2020)
Table 17. Global Transdermal Skin Patches Sales Market Share by Region (2015-2020)
Table 18. Global Transdermal Skin Patches Revenue (Million US$) by Region (2015-2020)
Table 19. Global Transdermal Skin Patches Revenue Market Share by Region (2015-2020)
Table 20. North America Transdermal Skin Patches Sales by Country (2015-2020) (K Pcs)
Table 21. North America Transdermal Skin Patches Sales Market Share by Country (2015-2020)
Table 22. North America Transdermal Skin Patches Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Transdermal Skin Patches Revenue Market Share by Country (2015-2020)
Table 24. Europe Transdermal Skin Patches Sales by Country (2015-2020) (K Pcs)
Table 25. Europe Transdermal Skin Patches Sales Market Share by Country (2015-2020)
Table 26. Europe Transdermal Skin Patches Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Transdermal Skin Patches Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Transdermal Skin Patches Sales by Region (2015-2020) (K Pcs)
Table 29. Asia Pacific Transdermal Skin Patches Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Transdermal Skin Patches Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Transdermal Skin Patches Revenue Market Share by Region (2015-2020)
Table 32. Latin America Transdermal Skin Patches Sales by Country (2015-2020) (K Pcs)
Table 33. Latin America Transdermal Skin Patches Sales Market Share by Country (2015-2020)
Table 34. Latin America Transdermal Skin Patches Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Transdermal Skin Patches Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Transdermal Skin Patches Sales by Country (2015-2020) (K Pcs)
Table 37. Middle East and Africa Transdermal Skin Patches Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Transdermal Skin Patches Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Transdermal Skin Patches Revenue Market Share by Country (2015-2020)
Table 40. Global Transdermal Skin Patches Sales (K Pcs) by Type (2015-2020)
Table 41. Global Transdermal Skin Patches Sales Share by Type (2015-2020)
Table 42. Global Transdermal Skin Patches Revenue (Million US$) by Type (2015-2020)
Table 43. Global Transdermal Skin Patches Revenue Share by Type (2015-2020)
Table 44. Global Transdermal Skin Patches Price (USD/Pcs) by Type (2015-2020)
Table 45. Global Transdermal Skin Patches Sales (K Pcs) by Application (2015-2020)
Table 46. Global Transdermal Skin Patches Sales Market Share by Application (2015-2020)
Table 47. Global Transdermal Skin Patches Sales Growth Rate by Application (2015-2020)
Table 48. Johnson & Johnson Transdermal Skin Patches Corporation Information
Table 49. Johnson & Johnson Description and Business Overview
Table 50. Johnson & Johnson Transdermal Skin Patches Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 51. Johnson & Johnson Main Product
Table 52. Johnson & Johnson Recent Development
Table 53. Novartis AG Transdermal Skin Patches Corporation Information
Table 54. Novartis AG Corporation Information
Table 55. Novartis AG Transdermal Skin Patches Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 56. Novartis AG Main Product
Table 57. Novartis AG Recent Development
Table 58. Mylan N.V. Transdermal Skin Patches Corporation Information
Table 59. Mylan N.V. Corporation Information
Table 60. Mylan N.V. Transdermal Skin Patches Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 61. Mylan N.V. Main Product
Table 62. Mylan N.V. Recent Development
Table 63. Teva Pharmaceutical Industries Transdermal Skin Patches Corporation Information
Table 64. Teva Pharmaceutical Industries Corporation Information
Table 65. Teva Pharmaceutical Industries Transdermal Skin Patches Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 66. Teva Pharmaceutical Industries Main Product
Table 67. Teva Pharmaceutical Industries Recent Development
Table 68. Luye Pharma Group Transdermal Skin Patches Corporation Information
Table 69. Luye Pharma Group Corporation Information
Table 70. Luye Pharma Group Transdermal Skin Patches Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 71. Luye Pharma Group Main Product
Table 72. Luye Pharma Group Recent Development
Table 73. Hisamitsu Pharmaceutical Transdermal Skin Patches Corporation Information
Table 74. Hisamitsu Pharmaceutical Corporation Information
Table 75. Hisamitsu Pharmaceutical Transdermal Skin Patches Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Hisamitsu Pharmaceutical Main Product
Table 77. Hisamitsu Pharmaceutical Recent Development
Table 78. Mundipharma International Transdermal Skin Patches Corporation Information
Table 79. Mundipharma International Corporation Information
Table 80. Mundipharma International Transdermal Skin Patches Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Mundipharma International Main Product
Table 82. Mundipharma International Recent Development
Table 83. Purdue Pharma Transdermal Skin Patches Corporation Information
Table 84. Purdue Pharma Corporation Information
Table 85. Purdue Pharma Transdermal Skin Patches Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Purdue Pharma Main Product
Table 87. Purdue Pharma Recent Development
Table 88. Sales Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Transdermal Skin Patches Distributors List
Table 91. Transdermal Skin Patches Customers List
Table 92. Market Key Trends
Table 93. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 94. Key Challenges
Table 95. Global Transdermal Skin Patches Sales (K Pcs) Forecast by Type (2021-2026)
Table 96. Global Transdermal Skin Patches Sales Market Share Forecast by Type (2021-2026)
Table 97. Global Transdermal Skin Patches Revenue (Million US$) Forecast by Type (2021-2026)
Table 98. Global Transdermal Skin Patches Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 99. Global Transdermal Skin Patches Sales (K Pcs) Forecast by Application (2021-2026)
Table 100. Global Transdermal Skin Patches Revenue (Million US$) Forecast by Application (2021-2026)
Table 101. Global Transdermal Skin Patches Sales (K Pcs) Forecast by Region (2021-2026)
Table 102. Global Transdermal Skin Patches Sales Market Share Forecast by Region (2021-2026)
Table 103. Global Transdermal Skin Patches Revenue Forecast by Region (2021-2026) (US$ Million)
Table 104. Global Transdermal Skin Patches Revenue Market Share Forecast by Region (2021-2026)
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Transdermal Skin Patches
Figure 2. Global Transdermal Skin Patches Sales Market Share by Type: 2020 VS 2026
Figure 3. Drug in Adhesive Product Picture
Figure 4. Matrix Product Picture
Figure 5. Reservoir Product Picture
Figure 6. Vapor Product Picture
Figure 7. Other Product Picture
Figure 8. Global Transdermal Skin Patches Consumption Market Share by Application: 2020 VS 2026
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Global Transdermal Skin Patches Market Size 2015-2026 (US$ Million)
Figure 13. Global Transdermal Skin Patches Sales Capacity (K Pcs) (2015-2026)
Figure 14. Global Transdermal Skin Patches Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Transdermal Skin Patches Sales Share by Manufacturers in 2020
Figure 16. Global Transdermal Skin Patches Revenue Share by Manufacturers in 2019
Figure 17. The Global 5 and 10 Largest Players: Market Share by Transdermal Skin Patches Revenue in 2019
Figure 18. Transdermal Skin Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Transdermal Skin Patches Sales Market Share by Region (2015-2020)
Figure 20. Global Transdermal Skin Patches Sales Market Share by Region in 2019
Figure 21. Global Transdermal Skin Patches Revenue Market Share by Region (2015-2020)
Figure 22. Global Transdermal Skin Patches Revenue Market Share by Region in 2019
Figure 23. North America Transdermal Skin Patches Sales Market Share by Country in 2019
Figure 24. North America Transdermal Skin Patches Revenue Market Share by Country in 2019
Figure 25. U.S. Transdermal Skin Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 26. U.S. Transdermal Skin Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Canada Transdermal Skin Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 28. Canada Transdermal Skin Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Europe Transdermal Skin Patches Sales Market Share by Country in 2019
Figure 30. Europe Transdermal Skin Patches Revenue Market Share by Country in 2019
Figure 31. Germany Transdermal Skin Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 32. Germany Transdermal Skin Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. France Transdermal Skin Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 34. France Transdermal Skin Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. U.K. Transdermal Skin Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.K. Transdermal Skin Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Italy Transdermal Skin Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Italy Transdermal Skin Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Russia Transdermal Skin Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Russia Transdermal Skin Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Asia Pacific Transdermal Skin Patches Sales Market Share by Region in 2019
Figure 42. Asia Pacific Transdermal Skin Patches Revenue Market Share by Region in 2019
Figure 43. China Transdermal Skin Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 44. China Transdermal Skin Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Japan Transdermal Skin Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Japan Transdermal Skin Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. South Korea Transdermal Skin Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. South Korea Transdermal Skin Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. India Transdermal Skin Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. India Transdermal Skin Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Australia Transdermal Skin Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Australia Transdermal Skin Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Taiwan Transdermal Skin Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Taiwan Transdermal Skin Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Indonesia Transdermal Skin Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Indonesia Transdermal Skin Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Thailand Transdermal Skin Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. Thailand Transdermal Skin Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Malaysia Transdermal Skin Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. Malaysia Transdermal Skin Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Philippines Transdermal Skin Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. Philippines Transdermal Skin Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Vietnam Transdermal Skin Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Vietnam Transdermal Skin Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Latin America Transdermal Skin Patches Sales Market Share by Country in 2019
Figure 66. Latin America Transdermal Skin Patches Revenue Market Share by Country in 2019
Figure 67. Mexico Transdermal Skin Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Mexico Transdermal Skin Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Brazil Transdermal Skin Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Brazil Transdermal Skin Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Argentina Transdermal Skin Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Argentina Transdermal Skin Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Middle East and Africa Transdermal Skin Patches Sales Market Share by Country in 2019
Figure 74. Middle East and Africa Transdermal Skin Patches Revenue Market Share by Country in 2019
Figure 75. Turkey Transdermal Skin Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Turkey Transdermal Skin Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Saudi Arabia Transdermal Skin Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Saudi Arabia Transdermal Skin Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. U.A.E Transdermal Skin Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. U.A.E Transdermal Skin Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Sales Market Share of Transdermal Skin Patches by Type (2015-2020)
Figure 82. Sales Market Share of Transdermal Skin Patches by Type in 2019
Figure 83. Revenue Share of Transdermal Skin Patches by Type (2015-2020)
Figure 84. Revenue Market Share of Transdermal Skin Patches by Type in 2019
Figure 85. Global Transdermal Skin Patches Sales Growth by Type (2015-2020) (K Pcs)
Figure 86. Global Transdermal Skin Patches Sales Market Share by Application (2015-2020)
Figure 87. Global Transdermal Skin Patches Sales Market Share by Application in 2019
Figure 88. Global Revenue Share of Transdermal Skin Patches by Application (2015-2020)
Figure 89. Global Revenue Share of Transdermal Skin Patches by Application in 2020
Figure 90. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Mylan N.V. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Luye Pharma Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Hisamitsu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Mundipharma International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Purdue Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Price Trend of Key Raw Materials
Figure 99. Manufacturing Cost Structure of Transdermal Skin Patches
Figure 100. Manufacturing Process Analysis of Transdermal Skin Patches
Figure 101. Transdermal Skin Patches Industrial Chain Analysis
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. North America Transdermal Skin Patches Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 106. North America Transdermal Skin Patches Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Transdermal Skin Patches Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Transdermal Skin Patches Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Transdermal Skin Patches Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Transdermal Skin Patches Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Transdermal Skin Patches Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Transdermal Skin Patches Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Transdermal Skin Patches Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Transdermal Skin Patches Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Bottom-up and Top-down Approaches for This Report
Figure 116. Data Triangulation
Figure 117. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs